<DOC>
	<DOC>NCT01864941</DOC>
	<brief_summary>To investigate the safety and tolerability of balloon venoplasty compared to sham in Multiple Sclerosis patients with Chronic Cerebrospinal Venous Insufficiency (CCSVI) as measured by adverse events occurring within 48 weeks of the procedure.</brief_summary>
	<brief_title>Interventional Clinical Trial for CCSVI in Multiple Sclerosis Patients</brief_title>
	<detailed_description>Overview of study objectives are: - To determine the safety and tolerability of venoplasty of CCSVI in Multiple Sclerosis (MS). - To determine the short term and long term impact on validated patient measures and by physician and radiologic reported MS outcomes. - To determine the short term and long term recurrence rate of CCSVI for veins that have been treated with venoplasty</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS) or Secondary Progressive MS according to the McDonald criteria 2010 Age 18 to 65 years inclusive Neurostatus (EDSS) score at screening from 0 to 6.5 Fulfill ultrasound criteria for CCSVI Previous venoplasty and/or stenting of extra cranial venous system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>MS</keyword>
	<keyword>CCSVI</keyword>
	<keyword>Zamboni</keyword>
	<keyword>catheter venography</keyword>
	<keyword>balloon angioplasty</keyword>
</DOC>